Shefali Agarwal Insider Trading
Get free email notifications about insider trading for Shefali Agarwal.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Shefali Agarwal. Shefali Agarwal is a Director in FATE THERAPEUTICS INC ($FATE) and a Chief Medical Officer in Epizyme, Inc. ($EPZM).
Address: C/O EPIZYME, INC. 400 TECHNOLOGY SQUARE CAMBRIDGE 02139 MA
Companies in which Shefali Agarwal is an Insider
Epizyme, Inc.
Trading Symbol: EPZMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Shefali Agarwal: Chief Medical Officer
Holdings: 104,341 shares
Current Value: $1,257,309
Latest Transaction: Feb 05 2021
$EPZM Market Capitalization: $707.73M
$EPZM Previous Close: $12.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
FATE THERAPEUTICS INC
Trading Symbol: FATEIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Shefali Agarwal: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 17 2019
$FATE Market Capitalization: $95.27M
$FATE Previous Close: $2.80
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Shefali Agarwal
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 05 2021 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Sell | S | 11.21 | 969 | 10,862 | 104,341 | 105.3 K to 104.3 K (-0.92 %) |
Feb 02 2021 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Option Exercise | A | 11.02 | 141,135 | 1,555,308 | 141,135 | |
Feb 02 2021 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Grant | A | 0.00 | 29,583 | 0 | 105,310 | 75.7 K to 105.3 K (+39.07 %) |
Jan 27 2021 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Sell | S | 11.41 | 2,872 | 32,770 | 75,727 | 78.6 K to 75.7 K (-3.65 %) |
Jun 30 2020 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Sell | S | 16.15 | 1,805 | 29,151 | 78,611 | 80.4 K to 78.6 K (-2.24 %) |
Jun 30 2020 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Grant | A | 0.00 | 6,000 | 0 | 80,416 | 74.4 K to 80.4 K (+8.06 %) |
Mar 26 2020 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Sell | S | 15.28 | 1,243 | 18,993 | 71,991 | 73.2 K to 72 K (-1.70 %) |